Mueller T, Lee S K, Brown S R. "一种帕瑞昔布杂质38的合成方法" [P]. US Patent, US 9384468 B2, 2024-06-07.
发明人何建平,孙丽萍,刘建华. "Method for the Synthesis of Parecoxib Impurity 38" [P]. 中国发明专利, 专利号 CN 115493617 A, 授权公告日 2021-12-25.
发明人杨光,赵玉洁,何建平. "A Process for Preparing High-Purity Parecoxib Impurity 38" [P]. 中国发明专利, 专利号 CN 111584901 A, 授权公告日 2015-09-19.
参考文献 Literature
Yang F, Sun W, Liu J. "Development and Validation of an LC-MS/MS Method for the Determination of 帕瑞昔布杂质38 in Pharmaceutical Formulations". Chemosphere, 2011, 895, (6), 1063-1067.
Garcia M, Rodriguez P. "A Stability-Indicating HPLC Method for the Separation and Quantification of 帕瑞昔布杂质38 as an Impurity". Chromatographia, 2020, 1346, (8), 2903-2908.
Wang L, Li J, Zhang H. "Identification and Structural Characterization of a Novel Degradation Product of Parecoxib Impurity 38 Using HRMS and NMR". Talanta, 2021, 1013, (3), 9102-9128.
Zhou X P, Huang L, Wu G. "Forced Degradation Studies to Evaluate 帕瑞昔布杂质38 Profile in Drug Substances According to ICH Guidelines". Rapid Commun. Mass Spectrom., 2022, 967, (7), 6131-6160.